Navigation Links
AMPAC Fine Chemicals Announces the Inauguration of the New cGMP Continuous Processing Development Facility
Date:3/9/2009

LAS VEGAS, March 9 /PRNewswire-FirstCall/ -- American Pacific Corporation (Nasdaq: APFC) is pleased to announce that its wholly-owned subsidiary, AMPAC Fine Chemicals LLC (AFC), located near Sacramento California, recently inaugurated a new kilogram scale cGMP Batch/Continuous Processing Development facility. The new facility can accommodate either batch reactors (20 to 50 liters) or AFC's continuous "zone reactor" technology using up to 7 reactors from 0.25 to 1 liter in volume.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090309/LA81048)

This new facility allows AFC to expand its scale-up capabilities. It will also be very useful in the demonstration of continuous reaction performance (throughput, yield and purity) using AFC's "zone-reactor" concept at significant scale (0.25 to 1 liter reactors). The new facility comprises two large walk-in hoods, a separate room for solid isolation using two dryers and two remote bays for handling energetic reactions.

Dr. Aslam Malik, President of AMPAC Fine Chemicals LLC, said "We are excited by the opening of this new facility. Through our history of handling energetic chemistry and highly potent compounds, AFC has developed an extensive knowledge and expertise in continuous processing. Smaller reactor volumes, smaller quantities of reactants, better yield and cleaner impurity profiles make the process safer, more reliable, and more economical than the traditional batch process. In an industry that has been traditionally batch, implementing continuous processing is not easy. However, due to the recent push by the FDA for Quality by Design and use of Process Analytical Technology, continuous processing is achieving greater acceptance in the pharmaceutical industry."

ABOUT AMPAC FINE CHEMICALS LLC

AFC is a U.S. based company with demonstrated capabilities in process development, scale-up, and cGMP-compliant commercial production of active pharmaceutical ingredients (API's) and registered intermediates for pharmaceutical and biotechnology customers. Its specially engineered facilities and experienced staff allow AFC to safely produce highly energetic compounds at commercial scale. In addition, AFC's other technology platforms include production of highly potent compounds, continuous processes and industrial-scale chromatographic separation using simulated moving bed chromatography (SMB).

ABOUT AMERICAN PACIFIC CORPORATION

American Pacific Corporation (AMPAC) is a leading custom manufacturer of fine chemicals, specialty chemicals and propulsion products within its focused markets. We supply active pharmaceutical ingredients and advanced intermediates to the pharmaceutical industry. For the aerospace and defense industry we provide specialty chemicals used in solid rocket motors for space launch and military missiles. AMPAC also designs and manufactures liquid propulsion systems, valves and structures for space and missile defense applications. We produce clean agent chemicals for the fire protection industry, as well as electro-chemical equipment for the water treatment industry. Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals. Additional information about us can be obtained by visiting our web site at www.apfc.com.


'/>"/>
SOURCE American Pacific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
2. Enerkem announces first commercial-scale biofuels and biochemicals plant is entering start-up phase
3. Sigma-Aldrich to Present at the 19th Annual Citi Chemicals Conference Tuesday, December 2, 2008
4. Detecting dangerous chemicals with lasers, exploring the brains circuitry with light and more
5. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
6. NIH collaborates with EPA to improve the safety testing of chemicals
7. ADM Forms Industrial Chemicals Group
8. Nile Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results and Announces Conference Call on March 10, 2009
9. Cell Therapeutics Announces Receipt of NASDAQ Listing Update
10. Canadian Government Announces Funding for Leading Biotechnology Firms Project
11. InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that its new website has gone ... story-driven, knowledge-based and mobile-friendly. Visit the new site: ... ... ... "The goal was to reimagine the ...
(Date:2/5/2016)... MANASSAS, Va. , Feb. 5, 2016 ... organization, is poised to assist the medical and life ... concerns around Zika Virus infection.   CDC ... --> Zika virus is a single-stranded ... also includes the West Nile, Dengue and Chikungunya Viruses. ...
(Date:2/5/2016)... SYDNEY , Feb. 5, 2016 Australian-US drug ... ), announced today the appointment of a new Chairman, Mr ... Bryce Carmine , effective immediately. James Garner ... an Executive Director and former Acting CEO, Mr Iain ... a Non-Executive Director. --> James Garner , has ...
(Date:2/4/2016)... (PRWEB) , ... February 04, 2016 , ... ... latest GC-MS and triple quad LC-MS, host live demos and poster sessions, and ... conference and exhibition. The conference takes place March 6 to 10 at the ...
Breaking Biology Technology:
(Date:2/1/2016)... , February 1, 2016 ... advancements to drive global touchfree intuitive gesture control market ... --> Rising sales of consumer electronics coupled with ... control market size through 2020 ... electronics coupled with new technological advancements to drive global ...
(Date:1/25/2016)... BLUE BELL, Pa. , Jan. 25, 2016   Unisys ... facial recognition system at John F. Kennedy (JFK) International Airport, ... and Border Protection (CBP) identify imposters attempting to enter ... or do not belong to them. pilot testing ... rolled out initially at three terminals at JFK during January 2016. ...
(Date:1/20/2016)... A market that just keeps on growing. ... explosion in genomics knowledge. Learn all about it in ... of dynamic trends are pushing market growth and company ... pharmacogenomics - pathogen evolution - next generation sequencing - ... understanding of the role of genetic material in Disease ...
Breaking Biology News(10 mins):